EFA
GOSS icon

Evernest Financial Advisors’s Gossamer Bio GOSS Stock Holding History

Evernest Financial Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10K Buy
28,769
+369
+1% +$580 ﹤0.01% 180
2025
Q4 		$64.2K Buy
28,400
+8,400
+42% +$24K 0.01% 183
2025
Q3 		$52.6K Buy
+20,000
New +$44.1K 0.01% 186

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Evernest Financial Advisors's GOSS Position: Q1 2026 in Review

Evernest Financial Advisors increased its Gossamer Bio (GOSS) stake by 1.3% in Q1 2026, buying an estimated $580 and bringing the position to 28,769 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #180.

Evernest Financial Advisors first reported a position in GOSS in Q3 2025 and has held it in 3 quarters since. The position peaked at $64.2K in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Evernest Financial Advisors held 28,769 shares of Gossamer Bio worth $10K as of Q1 2026.
  • Evernest Financial Advisors bought 369 Gossamer Bio shares in Q1 2026, an estimated $580.
  • Gossamer Bio made up ﹤0.01% of Evernest Financial Advisors's portfolio in Q1 2026, its #180 holding.
  • Evernest Financial Advisors first reported a position in Gossamer Bio in Q3 2025 and has held it in 3 quarters since.
  • Evernest Financial Advisors's Gossamer Bio position peaked at $64.2K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Evernest Financial Advisors's 13F filing for Q1 2026, filed 4 May 2026.